Log in to save to my catalogue

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3148255

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation

About this item

Full title

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation

Publisher

Waltham, MA: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2010-11, Vol.363 (21), p.1991-2003

Language

English

Formats

Publication information

Publisher

Waltham, MA: Massachusetts Medical Society

More information

Scope and Contents

Contents

In vitro studies have indicated that a molecule, VX-770, potentiates the activity of a mutant cystic fibrosis transmembrane conductance regulator (CFTR) protein. This trial involving persons with a copy of the mutant allele showed improvement in those who received the drug.
Cystic fibrosis is a progressive lung disease
1
caused by mutation...

Alternative Titles

Full title

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3148255

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3148255

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa0909825

How to access this item